Brief by Shorts91 Newsdesk / 07:10am on 19 Oct 2023,Thursday Business
Dabur India disclosed that its three foreign subsidiaries, Namaste Laboratories LLC, Dermoviva Skin Essentials Inc., and Dabur International Ltd., are facing 5,400 cases in federal and state courts in the US and Canada. Consumers allege certain hair relaxer products, containing specific chemicals, caused ovarian and uterine cancers. The cases, consolidated as Multi-District Litigation, are in the early litigation phases. While the financial impact remains uncertain, defense costs are expected to surpass materiality soon. Dabur emphasizes these claims are unproven. The litigation is ongoing, with outcomes and settlements undetermined.
